Skip to Content

Logo 660 (Ropinirole hydrochloride extended-release 8 mg)

Pill imprint Logo 660 has been identified as Ropinirole hydrochloride extended-release 8 mg.

Ropinirole is used in the treatment of restless legs syndrome; parkinson's disease; periodic limb movement disorder; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 8 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ropinirole hydrochloride extended-release 8 mg Logo 660
Ropinirole hydrochloride extended-release 8 mg Logo 660
Discount Card Promo
Ropinirole hydrochloride extended-release
Imprint:
Logo 660
Strength:
8 mg
Color:
Red
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Actavis Elizabeth LLC
National Drug Code (NDC):
00228-3660
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
castor oil
hypromelloses
lactose monohydrate
magnesium stearate
maltodextrin
titanium dioxide
ferric oxide red
polyethylene glycol
polyvinyl alcohol
magnesium silicate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
42291-0716 AvKare, Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide